Published in Liver Transpl on September 01, 2002
Current management strategy of hepatocellular carcinoma. World J Gastroenterol (2009) 1.79
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58
Efficacy of loco-regional ablation therapy of HCC in a population of liver transplanted patients. Dig Dis Sci (2007) 1.41
Liver transplantation, liver resection, and transarterial chemoembolization for hepatocellular carcinoma in cirrhosis: which is the best oncological approach? Dig Dis Sci (2008) 1.03
HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03
Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol (2007) 0.97
Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.86
Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis. World J Gastroenterol (2015) 0.82
What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma? Liver Transpl (2011) 0.80
Pre-liver transplant biopsy in hepatocellular carcinoma: a potential criterion for exclusion from transplantation? HPB (Oxford) (2012) 0.79
Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation. Cancer Imaging (2016) 0.79
Intent-to-treat analysis of liver transplant for hepatocellular carcinoma in the MELD era: impact of hepatitis C and advanced status. Dig Dis Sci (2014) 0.78
Surgical treatment for hepatocellular carcinoma. Saudi J Gastroenterol (2015) 0.77
Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clin Mol Hepatol (2014) 0.76
Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: What can we learn from the past era? World J Transplant (2016) 0.75
Liver transplantation for hepatocellular carcinoma: a single European centre experience. Langenbecks Arch Surg (2004) 0.75
Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med (2005) 4.05
Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl (2004) 3.46
Acute kidney injury following liver transplantation: definition and outcome. Liver Transpl (2009) 2.05
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria. Ann Surg (2016) 2.05
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation (2006) 1.94
Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis (2007) 1.78
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis (2009) 1.60
Twenty years of follow-up of aortohepatic conduits in liver transplantation. Liver Transpl (2008) 1.53
Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation (2004) 1.50
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience. Arch Pathol Lab Med (2006) 1.49
Development and validation of GFR-estimating equations using diabetes, transplant and weight. Nephrol Dial Transplant (2009) 1.46
Syndromic incidence of ovarian carcinoma after liver transplantation, with special reference to anteceding breast cancer. Dig Dis Sci (2003) 1.43
Modeling the allocation system: principles for robust design before restructuring. Transplantation (2015) 1.26
Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg (2002) 1.24
A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl (2003) 1.20
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl (2012) 1.18
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis (2005) 1.14
Predicting renal failure after liver transplantation from measured glomerular filtration rate: review of up to 15 years of follow-up. Transplantation (2010) 1.13
An outcome comparison between primary liver transplantation and retransplantation based on the pretransplant MELD score. Transpl Int (2006) 1.11
Cutaneous cryptococcosis in solid organ transplant recipients. Med Mycol (2010) 1.09
Allograft loss in renal transplant recipients with cryptococcus neoformans associated immune reconstitution syndrome. Transplantation (2005) 1.05
Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am J Transplant (2003) 1.05
Antifungal management practices and evolution of infection in organ transplant recipients with cryptococcus neoformans infection. Transplantation (2005) 1.02
De novo tumors after liver transplantation: a single-institution experience. Liver Transpl (2002) 1.00
Two-stage total hepatectomy and liver transplantation for acute deterioration of chronic liver disease: a new bridge to transplantation. Liver Transpl (2004) 1.00
Liver retransplantation for primary nonfunction: analysis of a 20-year single-center experience. Liver Transpl (2007) 0.99
Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology (2009) 0.99
Liver and intestine transplantation. Am J Transplant (2004) 0.97
Late acute rejection after liver transplantation impacts patient survival. Clin Transplant (2008) 0.96
Pancreatic islet cell transplantation: a treatment strategy for type I diabetes mellitus. Nutr Clin Pract (2004) 0.96
Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome. Transplantation (2006) 0.96
Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis (2008) 0.95
Unrecognized pretransplant and donor‐derived cryptococcal disease in organ transplant recipients. Clin Infect Dis (2010) 0.94
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother (2007) 0.94
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial. Liver Transpl (2004) 0.93
Hepatorenal syndrome: a proposal for kidney after liver transplantation (KALT). Liver Transpl (2007) 0.93
Survival after liver transplantation: Is racial disparity inevitable? Hepatology (2007) 0.93
Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings. Transplantation (2008) 0.92
Acute graft-versus-host disease after liver transplantation: role of withdrawal of immunosuppression in therapeutic management. Liver Transpl (2007) 0.91
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl (2002) 0.90
Societal reintegration after liver transplantation: findings in alcohol-related and non-alcohol-related transplant recipients. Ann Surg (2004) 0.90
Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl (2002) 0.90
The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation. Transplantation (2003) 0.89
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. Transplantation (2002) 0.88
Liver transplantation and health-related quality of life: scoring differences between men and women. Liver Transpl (2004) 0.88
YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study. Clin Transplant (2010) 0.88
Clinical outcomes from hepatic artery stenting in liver transplantation. Liver Transpl (2006) 0.87
Radiofrequency thermal ablation of hepatocellular carcinoma before liver transplantation--a clinical and histological examination. Clin Transplant (2006) 0.86
One hundred human pancreatic islet isolations at Baylor Research Institute. Proc (Bayl Univ Med Cent) (2010) 0.86
Indications for combined liver and kidney transplantation: propositions after a 23-yr experience. Clin Transplant (2010) 0.85
A meta-analysis for comparison of the two-layer and university of Wisconsin pancreas preservation methods in islet transplantation. Cell Transplant (2010) 0.83
Malpositioned transjugular intrahepatic portosystemic shunt in the common hepatic duct leading to biliary obstruction and liver transplantation. Liver Transpl (2011) 0.83
Liver transplantation for hepatocellular carcinoma: the Baylor experience. J Hepatobiliary Pancreat Sci (2009) 0.82
Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl (2009) 0.82
Treatment of unresectable hepatoblastoma with liver transplantation in the pediatric population. Am J Transplant (2002) 0.82
Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr Transplant (2003) 0.82
Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. Transpl Immunol (2006) 0.80
Cadaveric orthotopic auxiliary split liver transplantation and kidney transplantation: an alternative for type 1 primary hyperoxaluria. Transplantation (2005) 0.79
False aneurysm of a hepatic artery branch complicating intrahepatic islet transplantation. Transpl Int (2009) 0.79
Successful combined liver and kidney transplant for COACH syndrome and 5-yr follow-up. Clin Transplant (2005) 0.79
Immunosuppression for delayed or slow graft function in primary cadaveric renal transplantation: use of low dose tacrolimus therapy with post-operative administration of anti-CD25 monoclonal antibody. Clin Transplant (2002) 0.79
Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology. Transplantation (2011) 0.79
Pancreatic islet cell transplantation: update and new developments. Nutr Clin Pract (2007) 0.79
Twenty years' follow-up of portal vein conduits in liver transplantation. Liver Transpl (2009) 0.78
Sirolimus and cardiovascular disease risk in liver transplantation. Transplantation (2013) 0.78
Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation (2010) 0.78
Implications of a positive crossmatch in liver transplantation: a 20-year review. Liver Transpl (2012) 0.77
Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med (2003) 0.76
Geographic differences in disease expression of cryptococcosis in solid organ transplant recipients in the United States. Ann Transplant (2010) 0.76
Liver transplantation for cystic fibrosis in adults. Surg Today (2007) 0.76
Graft-vs-host disease as a complication of lung transplantation. J Heart Lung Transplant (2006) 0.76
Ratio of hepatic arterial flow to recipient body weight predicts biliary complications after deceased donor liver transplantation. HPB (Oxford) (2014) 0.75
Renal-sparing regimens employing new agents. Curr Opin Organ Transplant (2012) 0.75
The question of induction? Maybe not all antibodies are equal …*. Transpl Int (2011) 0.75
Hepatitis C and mycophenolate mofetil--a clarification. Liver Transpl (2002) 0.75
The Authors' Reply. Transplantation (2015) 0.75
Chronic AMR in Liver Transplant: Validation of the 1-Year cAMR score's Ability to Determine Long-Term Outcome. Transplantation (2017) 0.75
Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation. Clin Transplant (2013) 0.75
Xanthomas disappear rapidly after liver transplantation for familial hypercholesterolemia. Liver Transpl (2003) 0.75
The Authors' Reply. Transplantation (2017) 0.75
Unusually high incidence of positive HTLV I/II results among young female organ donors in the peripartum period. Dig Dis Sci (2002) 0.75
A Concentric-Neighborhoods Solution to Disparity in Liver Access that contains current UNOS Districts. Transplantation (2017) 0.75
Segmental biliary duct N-butyl cyanoacrylate ablation in a transplant liver for a biliary leak after hepaticojejunostomy. Liver Transpl (2014) 0.75
Pseudohypocalcemia after magnetic resonance imaging with gadolinium in patients with cirrhosis. Liver Transpl (2004) 0.75
Authors' Reply: Does low Hepatic Artery Flow Increase Rate of Biliary Strictures in Deceased Donor Liver Transplantation? Transplantation (2017) 0.75
Non-HLA Antibodies Impact on C4d staining, Stellate Cell Activation and Fibrosis in Liver Allografts. Transplantation (2017) 0.75
Low measured hepatic artery flow increases rate of biliary strictures in deceased donor liver transplantation: An age dependent phenomenon. Transplantation (2016) 0.75
The Baylor Regional Transplant Institute: review of a twenty-year experience. Clin Transpl (2004) 0.75